Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $387.5400 (0.81%) ($384.5000 - $388.3900) on Wed. Nov. 22, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.67% (three month average) | | RSI | 45 | | Latest Price | $387.5400(0.81%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) QQQ(43%) XBI(43%) | | Factors Impacting REGN price | REGN will decline at least -0.835% in a week (0% probabilities).
UUP(-10%) VIXM(-7%) TLT(-6%) TIP(-1%) SHY(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.835% (StdDev 1.67%) | | Hourly BBV | 0 () | | Intraday Trend | 0.8% | | | | | |
|
| Resistance Level | $398.63 | | 5 Day Moving Average | $388.7(-0.3%) | | 10 Day Moving Average | $391.54(-1.02%) | | 20 Day Moving Average | $398.63(-2.78%) | | To recent high | -23.1% | | To recent low | 0.8% | | Market Cap | $41.09b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |